annual CFF:
$713.24M+$653.69M(+1097.75%)Summary
- As of today (June 17, 2025), JANX annual cash flow from financing activities is $713.24 million, with the most recent change of +$653.69 million (+1097.75%) on December 31, 2024.
- During the last 3 years, JANX annual CFF has risen by +$326.71 million (+84.53%).
- JANX annual CFF is now at all-time high.
Performance
JANX Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$554.00K-$386.10M(-99.86%)Summary
- As of today (June 17, 2025), JANX quarterly cash flow from financing activities is $554.00 thousand, with the most recent change of -$386.10 million (-99.86%) on March 31, 2025.
- Over the past year, JANX quarterly CFF has dropped by -$321.62 million (-99.83%).
- JANX quarterly CFF is now -99.86% below its all-time high of $386.65 million, reached on December 31, 2024.
Performance
JANX quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$391.62M-$321.62M(-45.09%)Summary
- As of today (June 17, 2025), JANX TTM cash flow from financing activities is $391.62 million, with the most recent change of -$321.62 million (-45.09%) on March 31, 2025.
- Over the past year, JANX TTM CFF has increased by +$11.48 million (+3.02%).
- JANX TTM CFF is now -45.09% below its all-time high of $713.24 million, reached on December 31, 2024.
Performance
JANX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
JANX Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1097.8% | -99.8% | +3.0% |
| 3 y3 years | +84.5% | +10000.0% | +19.0% |
| 5 y5 years | +10000.0% | -63.2% | +10000.0% |
JANX Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | >+9999.0% | -99.9% | >+9999.0% | -45.1% | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | -99.9% | +165.7% | -45.1% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -99.9% | +165.7% | -45.1% | >+9999.0% |
JANX Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $554.00K(-99.9%) | $391.62M(-45.1%) |
| Dec 2024 | $713.24M(+1097.7%) | $386.65M(>+9900.0%) | $713.24M(+117.8%) |
| Sep 2024 | - | $1.65M(-40.4%) | $327.42M(-14.4%) |
| Jun 2024 | - | $2.77M(-99.1%) | $382.38M(+0.6%) |
| Mar 2024 | - | $322.17M(>+9900.0%) | $380.14M(+538.4%) |
| Dec 2023 | $59.55M(>+9900.0%) | $831.00K(-98.5%) | $59.55M(+1.1%) |
| Sep 2023 | - | $56.61M(>+9900.0%) | $58.91M(+2462.3%) |
| Jun 2023 | - | $528.00K(-66.6%) | $2.30M(+10.6%) |
| Mar 2023 | - | $1.58M(+727.2%) | $2.08M(+315.8%) |
| Dec 2022 | $500.00K | $191.00K(>+9900.0%) | $500.00K(+5.7%) |
| Sep 2022 | - | $0.00(-100.0%) | $473.00K(-227.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $308.00K(>+9900.0%) | -$370.00K(-100.1%) |
| Mar 2022 | - | $1000.00(-99.4%) | $328.98M(-14.9%) |
| Dec 2021 | $386.52M(+3254.1%) | $164.00K(-119.5%) | $386.52M(-1.1%) |
| Sep 2021 | - | -$843.00K(-100.3%) | $390.91M(-0.2%) |
| Jun 2021 | - | $329.66M(+472.9%) | $391.72M(+479.8%) |
| Mar 2021 | - | $57.55M(+1163.9%) | $67.57M(+486.3%) |
| Dec 2020 | $11.52M(+188.1%) | $4.55M(<-9900.0%) | $11.52M(+65.3%) |
| Sep 2020 | - | -$33.00K(-100.6%) | $6.97M(-0.5%) |
| Jun 2020 | - | $5.50M(+265.7%) | $7.00M(+365.7%) |
| Mar 2020 | - | $1.50M | $1.50M |
| Dec 2019 | $4.00M | - | - |
FAQ
- What is Janux Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Janux Therapeutics?
- What is Janux Therapeutics annual CFF year-on-year change?
- What is Janux Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Janux Therapeutics?
- What is Janux Therapeutics quarterly CFF year-on-year change?
- What is Janux Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Janux Therapeutics?
- What is Janux Therapeutics TTM CFF year-on-year change?
What is Janux Therapeutics annual cash flow from financing activities?
The current annual CFF of JANX is $713.24M
What is the all time high annual CFF for Janux Therapeutics?
Janux Therapeutics all-time high annual cash flow from financing activities is $713.24M
What is Janux Therapeutics annual CFF year-on-year change?
Over the past year, JANX annual cash flow from financing activities has changed by +$653.69M (+1097.75%)
What is Janux Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of JANX is $554.00K
What is the all time high quarterly CFF for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash flow from financing activities is $386.65M
What is Janux Therapeutics quarterly CFF year-on-year change?
Over the past year, JANX quarterly cash flow from financing activities has changed by -$321.62M (-99.83%)
What is Janux Therapeutics TTM cash flow from financing activities?
The current TTM CFF of JANX is $391.62M
What is the all time high TTM CFF for Janux Therapeutics?
Janux Therapeutics all-time high TTM cash flow from financing activities is $713.24M
What is Janux Therapeutics TTM CFF year-on-year change?
Over the past year, JANX TTM cash flow from financing activities has changed by +$11.48M (+3.02%)